University of Florida College of Medicine – Jacksonville
Gastroenterology fellowship · Jacksonville, FL · Program website
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Florida's research in gastroenterology, which the program shares with other departments and affiliated hospitals.
About University of Floridainstitution-wide gastroenterology research
Gastroenterology publications from University of Florida and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
93
works per year
10th of 77 gastroenterology fellowship programs
+4.4%
2-year growth
42nd of 76 gastroenterology fellowship programs
29.4%
in top 10% of field (works before 2025)
22nd of 66 gastroenterology fellowship programs
50.0%
cited above world average
29th of 66 gastroenterology fellowship programs
Works per year · * 2026 so far
Hepatology · 258Gastroenterology · 202
Gastroenterology research topics at University of Florida
Papers in the window; each links to the list on OpenAlex.
- Liver Disease Diagnosis and Treatment 120
- Gallbladder and Bile Duct Disorders 51
- Inflammatory Bowel Disease 49
- Hepatocellular Carcinoma Treatment and Prognosis 42
- Liver Disease and Transplantation 41
- Gastroesophageal reflux and treatments 33
- Hepatitis C virus research 30
- Gastrointestinal motility and disorders 30
Most cited at University of Florida since 2024
All gastroenterology papers there on OpenAlex
- Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes AssociationKenneth J. Cusi et al. · Diabetes Care · 2025 · PubMed · cited 396
- Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice GuidanceVincent Lingzhi Chen et al. · Hepatology · 2024 · PubMed · cited 227
- Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient CareJuan Patricio Nogueira et al. · Diabetes Spectrum · 2024 · PubMed · cited 126
- Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitisMaximilian Jara et al. · Nature Medicine · 2025 · PubMed · cited 110
- Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLDDiana Barb et al. · Journal of Hepatology · 2025 · PubMed · cited 100
- The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated SteatohepatitisLayla A. Abushamat et al. · Clinical Gastroenterology and Hepatology · 2024 · PubMed · cited 97
- American Society for Gastrointestinal Endoscopy guideline on the role of therapeutic EUS in the management of biliary tract disorders: summary and recommendationsSwati Pawa et al. · Gastrointestinal Endoscopy · 2024 · PubMed · cited 90
- American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: summary and recommendationsMadhav Desai et al. · Gastrointestinal Endoscopy · 2024 · PubMed · cited 88
- Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future TherapiesIdoia Genua et al. · Diabetes Spectrum · 2024 · PubMed · cited 74
- Addressing the High and Rising Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ) and Metabolic Dysfunction‐Associated Steatohepatitis ( MASH ): From the Growing Prevalence to Payors' PerspectiveZobair M. Younossi et al. · Alimentary Pharmacology & Therapeutics · 2025 · PubMed · cited 65